Keep heart with ResMed

Excitement is building over the benefits of ventilation therapy for heart failure patients, and it's encouragement enough for us to raise our price guide.

The excitement appears to be building around the benefits of ResMed’s ventilation therapy for heart failure patients, judging by its share price, which has soared 20% since our update on its interim result on 23 January and 73% since ResMed set to awaken on 14 Oct 14 (Buy – $5.44).

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles